Veeva Systems Inc. (LON:0LO3)
168.46
-8.99 (-5.06%)
Feb 12, 2026, 5:02 PM GMT
Veeva Systems Market Cap
Veeva Systems has a market cap or net worth of 21.33 billion as of February 12, 2026. Its market cap has decreased by -27.35% in one year.
Market Cap
21.33B
Enterprise Value
16.53B
Revenue
2.35B
Ranking
n/a
PE Ratio
32.56
Stock Price
168.46
Market Cap Chart
Since October 16, 2013, Veeva Systems's market cap has increased from 2.85B to 21.33B, an increase of 647.57%. That is a compound annual growth rate of 17.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 22.49B | -17.52% |
| Dec 31, 2025 | 27.26B | - |
| Dec 31, 2024 | 27.27B | 12.03% |
| Dec 29, 2023 | 24.34B | 16.71% |
| Dec 30, 2022 | 20.85B | -28.12% |
| Dec 31, 2021 | 29.01B | -3.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.75B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.40B |
| Hikma Pharmaceuticals | 3.41B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |